On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023. Among the Act’s many provisions is the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which significantly expands the U.S. Food and Drug Administration’s (FDA) regulation of cosmetic products1 in the United States. The MoCRA amends the Federal Food, Drug, and Cosmetic Act (FDCA) and imposes extensive new requirements related to cosmetic products, as described below.